 "India Coronavirus Dispatch: Over 1,700 new deaths in record daily spike")
As many as 1,761 new fatalities
India reported 259,170 fresh coronavirus cases on Tuesday, taking the cumulative tally to 15.3 million infections, according to central health ministry data. The country has registered over 200,000 cases for the sixth day in a row. The country saw 1,761 deaths due to the pandemic, taking the death toll to 180,530. This is the highest single-day rise in deaths so far. The active caseload is at 2 million infections, while the total recoveries have surged to 13.1 million. As many as 127 million shots have been administered since the nationwide inoculation programme kicked off on January 16. Of these, 3.2 million were given on Monday. Read more here
Indians are self-prescribing ivermectin, HCQ, dexamethasone
In a growing trend, Indians are now taking Covid drugs—normally given to people in hospitals immediately after testing positive—without a prescription, a report in ThePrint said. These patients turn up at hospitals in later stages and confess to consuming "known Covid drugs” such as hydroxychloroquine (HCQ), ivermectin, doxycycline and dexamethasone to prevent “severe” disease. Read more here
More zero-to-19-year-olds hospitalised in the second wave
The proportion of zero-to-19-year-olds affected in the second wave of Covid-19 has seen a slight increase from the first wave, according to a report in ThePrint that cited an analysis of data for hospitalised patients. Around 5.8 per cent of the patients hospitalised during the second wave of Covid-19 are from this age group, compared to 4.2 per cent in the first wave, from September to November 2020, according to the analysis.
Read more here
EXPLAINED: The ban on US exports of vaccine raw materials
US exports of key raw materials used in the production of some Covid-19 vaccines have been blocked as a result of President Joe Biden’s decision to invoke the US Defense Production Act earlier this year, an explainer in The Indian Express said. While the 1950 Act was originally passed to help ensure supplies during the Korean War, its scope today extends beyond the military to cover natural hazards, terrorist attacks and other national emergencies. Through this law, the US President can order domestic businesses to prioritise federal contracts in such events. Read more here
Regulate remdesivir, but ensure regular supply: Madhya Pradesh HC
Amid a surge in coronavirus cases, the Madhya Pradesh high court has asked the state government to ensure a regular supply of medical oxygen and life-saving drugs such as Remdesivir used in the treatment of Covid-19, a report in the Hindustan Times said. Hearing five petitions that alleged the state government had failed to deal with the spike in cases, the court said, “the state government may regulate the supply of Remdesivir injections and other lifesaving drugs, but the process adopted for this purpose should be hassle-free and should not be cumbersome so as to ensure the supply of the drug in such a way that the time limit from requisition by the treating doctors and supply of medicines does not exceed an hour”. Read more here
India reported 259,170 fresh coronavirus cases on Tuesday, taking the cumulative tally to 15.3 million infections, according to central health ministry data. The country has registered over 200,000 cases for the sixth day in a row. The country saw 1,761 deaths due to the pandemic, taking the death toll to 180,530. This is the highest single-day rise in deaths so far. The active caseload is at 2 million infections, while the total recoveries have surged to 13.1 million. As many as 127 million shots have been administered since the nationwide inoculation programme kicked off on January 16. Of these, 3.2 million were given on Monday. Read more here
Indians are self-prescribing ivermectin, HCQ, dexamethasone
In a growing trend, Indians are now taking Covid drugs—normally given to people in hospitals immediately after testing positive—without a prescription, a report in ThePrint said. These patients turn up at hospitals in later stages and confess to consuming "known Covid drugs” such as hydroxychloroquine (HCQ), ivermectin, doxycycline and dexamethasone to prevent “severe” disease. Read more here
More zero-to-19-year-olds hospitalised in the second wave
The proportion of zero-to-19-year-olds affected in the second wave of Covid-19 has seen a slight increase from the first wave, according to a report in ThePrint that cited an analysis of data for hospitalised patients. Around 5.8 per cent of the patients hospitalised during the second wave of Covid-19 are from this age group, compared to 4.2 per cent in the first wave, from September to November 2020, according to the analysis.
Read more here
EXPLAINED: The ban on US exports of vaccine raw materials
US exports of key raw materials used in the production of some Covid-19 vaccines have been blocked as a result of President Joe Biden’s decision to invoke the US Defense Production Act earlier this year, an explainer in The Indian Express said. While the 1950 Act was originally passed to help ensure supplies during the Korean War, its scope today extends beyond the military to cover natural hazards, terrorist attacks and other national emergencies. Through this law, the US President can order domestic businesses to prioritise federal contracts in such events. Read more here
Regulate remdesivir, but ensure regular supply: Madhya Pradesh HC
Amid a surge in coronavirus cases, the Madhya Pradesh high court has asked the state government to ensure a regular supply of medical oxygen and life-saving drugs such as Remdesivir used in the treatment of Covid-19, a report in the Hindustan Times said. Hearing five petitions that alleged the state government had failed to deal with the spike in cases, the court said, “the state government may regulate the supply of Remdesivir injections and other lifesaving drugs, but the process adopted for this purpose should be hassle-free and should not be cumbersome so as to ensure the supply of the drug in such a way that the time limit from requisition by the treating doctors and supply of medicines does not exceed an hour”. Read more here
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%